Key result
HCM-linked ACTN2 variants compromise protein integrity via reduced stability, altered actin-binding, and increased aggregation.
Why the study?
Variants in ACTN2 have been implicated in HCM, but their structural consequences remain poorly defined.
HCM-linked ACTN2 variants compromise protein integrity through multiple mechanisms, highlighting the actin-binding domain as a hotspot of structural vulnerability.
Answers are grounded in this paper and cite their sources.
ACTN2 variant protein instability may drive HCM pathogenesis; leaves open targeted interventions pending human cardiomyocyte validation.
Hypertrophic cardiomyopathy (HCM) is a genetic disease associated with sudden cardiac death. Variants in alpha-actinin-2 (ACTN2), a Z-disc protein that anchors actin thin filaments have been implicated in HCM, yet their structural consequences remain poorly defined. Here, we characterise seventeen HCM-associated ACTN2 variants spanning multiple domains using an integrated and tiered workflow combining high-throughput assays, structural modelling and biophysical approaches. All variants display reduced solubility, with actin-binding domain (ABD) substitutions showing pronounced thermal instability by differential scanning fluorimetry. Modelling of nine variants predicts diverse pathogenic mechanisms including compromised actin-binding, impaired ABD regulatory conformations, disrupted dimerisation interfaces, and perturbed domain architecture. Crystal structures of two rod-domain variants reveal intact dimerisation despite modelling predictions. Actin-binding assays for ABD variants confirm altered actin engagement suggesting that binding dynamics may drive pathogenicity. Limited proteolysis indicates reduced structural stability across variants, while size-exclusion chromatography coupled with multi-angle light scattering or small-angle X-ray scattering (SEC-MALS/SAXS) shows a strong propensity for aggregation. Batch-mode SAXS further demonstrates early aggregation onset in selected ABD variants at elevated temperatures. Collectively, these findings establish that HCM-linked ACTN2 variants compromise protein integrity through multiple mechanisms, highlight the ABD as a hotspot of vulnerability and provide a potential framework for interpreting cardiomyopathy-associated variants.
No takes yet. Share an insight, caveat, or question.
Noureddine et al. (2026) studied Hypertrophic cardiomyopathy. ACTN2 variants vs. Wild-type ACTN2 was evaluated on Protein solubility, thermal stability, actin-binding, and aggregation propensity. HCM-linked ACTN2 variants compromise protein integrity through multiple mechanisms, including reduced solubility, thermal instability, altered actin engagement, and increased aggregation propensity.
Synapse has enriched 10 related papers. Consider them for comparative context: